Navigation Links
Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
Date:11/6/2010

THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., Nov. 6, 2010 /PRNewswire/ -- Amgen Inc. (Nasdaq: AMGN), Pfizer Inc. (NYSE: PFE) and world-class professional golfer Phil Mickelson, have entered into a partnership to share Phil's experience with his diagnosis of psoriatic arthritis and treatment with Enbrel® (etanercept), and to encourage patients with similar symptoms to visit their doctor for proper assessment and care.

"This partnership with Amgen and Pfizer is important because being a psoriatic arthritis patient has motivated me to share my story," said Phil Mickelson. "I hope to encourage other patients to work with their doctors, learn about their condition and take action so that they have an opportunity to get back to some of the things that matter most to them."

Psoriatic arthritis is a form of arthritis caused by an overactive immune system that can affect not only the body's joints but also the skin. Approximately 600,000 Americans may have psoriatic arthritis. The main joint symptoms of psoriatic arthritis are pain, stiffness and swelling. Rheumatoid arthritis patients experience similar symptoms, however there are important differences between the two conditions, making it important to see a doctor.

Amgen and Pfizer were inspired by Mickelson's approach to managing his condition and by his continued drive to maintain his health. Those same qualities have kept him on top of the competitive world of golf and this is why the companies are excited to be partnering with him. Amgen and Pfizer believe his perseverance in the face of adversity will encourage patients to also work with their doctors to manage their condition and help them get back on course.

Further details and timing of future partnership initiatives will be announced in 2011.

About ENBRELE
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
2. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
3. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
4. NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
5. Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond
6. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
7. Professional Liability Costs for Hospitals and Physicians Continue to Rise, Outpacing Inflation
8. UBM Medica Presents Diagnostic Imaging LIVE, a Virtual Conference for Radiologists and Imaging Professionals - Now Available On Demand
9. Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya
10. Octapharma USA Launches Web Resource for von Willebrand Disease Healthcare Professionals and Patients
11. New Hope in Austin, Texas for Children Dealing with Social, Academic and Behavioral Issues; Austin Brain Balance Achievement Centers Grand Opening to Include Lectures for Parents, Teachers and Health Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014  VentiRx Pharmaceuticals, Inc., a ... development and commercialization of novel Toll-like receptor ... U.S. Food and Drug Administration (FDA) has ... of motolimod (VTX-2337) when administered in combination ... treatment of women with ovarian cancer whose ...
(Date:9/2/2014)... , Sept. 2, 2014 Bluegrass ... company focused on innovating lifesaving devices and methods ... of Dr. Gabriele Niederauer , a seasoned ... Following the recent closure of Series A financing, ... the Surfacer™ Inside-Out Access Catheter System, a proprietary ...
(Date:9/2/2014)... LAUSANNE , Switzerland , ... after receiving ISO 13485 accreditation, Sophia Genetics has become ... mark for the clinical use of a Next Generation Sequencing ... assurance certification represents an important step in raising ... diagnosis, and brings Sophia Genetics, world-leading Data Driven ...
Breaking Medicine Technology:VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer 2VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer 3Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO 2Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing 2
... 20 The District of Columbia Patients, Cooperative ... the District of Columbia, has submitted comments to the ... on proposed regulations announced 45 days ago.   ... http://www.dcpatients.org/DCPC_comments.pdf along with the comments of cannabis ...
... NewBridge Pharmaceuticals FZ-LLC of Dubai, UAE announced today that ... Executive Officer and a member of the company,s Board ... joins NewBridge after a career extending over 29 years ... positions covering many geographies including; US, Europe, and Middle ...
Cached Medicine Technology:DC Patients' Cooperative Urges Changes to the Proposed Medical Cannabis 'Marijuana' Regulations 2NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments 2NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments 3
(Date:9/2/2014)... September 02, 2014 As an industry transformation ... an industry and predict change. Fortunately for him, that valuable ... to identify markets that are eager for change — such ... the hearing aid market indicated it was ripe for better ... Sapio explained. As a result, he took matters into his ...
(Date:9/2/2014)... available in Spanish . ... through an experiment conducted on rats, that hyperproteic diets could ... for groups with bone disease problems, such as the elderly ... vegetal proteinin the case of the present study, soy proteinis ... former increased the level of calcium in bones by as ...
(Date:9/2/2014)... in their work care for patients who are dying. ... that many nurses in training feel unprepared and anxious ... end-of-life care. , Scientists from the Sahlgrenska Academy have ... the University of Skvde and the Ersta Skndal University ... for dying patients, their ideas about how to support ...
(Date:9/2/2014)... 2014 Catalent, the leading global ... for drugs, biologics and consumer health products, today ... Eli Lilly’s growth, it is to install new ... Philadelphia Clinical Supply Center of Excellence. , Catalent ... its clinical supply facility in Schorndorf, Germany, providing ...
(Date:9/2/2014)... 02, 2014 Splashtop Inc. , ... partnership with NTT DoCoMo to deliver Splashtop ... Splashtop Business Lite is included in NTT DoCoMo’s “Business ... desktop software that empower users to remote access their ... garnered over 18 million users worldwide. Splashtop delivers ...
Breaking Medicine News(10 mins):Health News:David Sapio Launches Zounds Hearing Franchise 2Health News:Study conducted on rats suggests that hyperproteic diets can be beneficial for bones 2Health News:Many nurses unprepared to meet dying patients 2Health News:Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions 2Health News:Splashtop and NTT DoCoMo Partner to Deliver “Splashtop Business Lite” Secure Remote Access Solution to Business Customers 2
... discovery in a Florida State University College of Medicine ... to one day help scientists learn how to stop ... are forming. , Jamila Horabin, associate professor of biomedical ... four-year, $1.2 million grant from the National Institutes of ...
... develop a custom solution for The Kidney Foundation of Canada that will ... ... (Vocus) January 9, 2009 -- Blackbaud, Inc. (Nasdaq: BLKB ) today ... of Canada that will create a unified national CRM and web presence., ...
... (PHILADELPHIA) Efforts to fight the toll of cardiac ... CPR education and improvement, public defibrillation programs, and quicker ... Pennsylvania School of Medicine reveals that the hospital where ... key role in their chances of survival following these ...
... Both a Membership Card and Debit Card for Health-related ExpensesPITTSBURGH, ... inconvenience often associated with a Flexible Spending Account (FSA) with ... card - which is unique to Western Pennsylvania - serves ... a debit card for out-of-pocket health care expenses.The My ...
... More than 1,800 in Florida Alone ST. PETERSBURG, Fla., ... franchise, announced today the launch of its low-cost, home-based ... consumers containing their comprehensive medical history. eMed-ID is ... medical history on an easy-to-carry or wearable USB device. ...
... to tomorrow,s (and even today,s) health problems may be ... 2009 Consumer Electronics ShowLAS VEGAS, Jan. 9 ... technology changing the way we shop, listen to music, ... family. However, managing an illness or disability remains a ...
Cached Medicine News:Health News:Researcher wins $1.2 million grant for gene regulation work 2Health News:Blackbaud to Deliver National CRM Database and Bilingual Website for The Kidney Foundation of Canada 2Health News:Blackbaud to Deliver National CRM Database and Bilingual Website for The Kidney Foundation of Canada 3Health News:Blackbaud to Deliver National CRM Database and Bilingual Website for The Kidney Foundation of Canada 4Health News:Penn study: Chances of surviving cardiac arrest depend on where patients are treated 2Health News:Penn study: Chances of surviving cardiac arrest depend on where patients are treated 3Health News:UPMC Health Plan Introduces `MyFlex Advantage' Card 2Health News:UPMC Health Plan Introduces `MyFlex Advantage' Card 3Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 2Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 3Health News:Meridian Makes CES Good For Your Health 2
... The dual lumen ... a 1.2 mm inner ... ,Dual oval lumen catheters ... while maintaining maximum catheter ...
The mid-sized titanium port is about 3/4 the diameter and half the weight of the standard model. The silicone catheter has an I.D. of 1.0 mm....
The WaveMap provides immediate clinical decision making information with automatic calculation of pressure gradients and FFR measurements.,SmartWire Pressure Guide Wire - The intelligent choice in ...
... Used for vascular access. ... facilitates single wall puncture with ... sideport is visualized while maintaining ... Sideport exits the hub of ...
Medicine Products: